Navigation Links
Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
Date:8/22/2007

A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists. The project, conducted jointly in the Schools of Pharmacy, Biomedical Sciences and Human Development, will be featured in the September issue of the Experimental Biology and Medicine.

Therapy for brain cancers is particularly difficult for a number of reasons, including getting sufficient drug to the tumor and selectivity of drug action. We are working on a number of new therapeutic approaches using nanoparticle drug delivery systems explained Dr Martin Garnett, Associate Professor of drug delivery at the School of Pharmacy, however, understanding and developing these systems requires suitable models for their evaluation.

The nanoparticles used in this study were prepared from a novel biodegradable polymer poly(glycerol adipate). The polymer has been further modified to enhance incorporation of drugs and make the nanoparticles more effective.

The interaction of tumor cells with brain cells varies between different tumors and different locations within the brain explained Dr Terence Parker, Associate Professor in the School of Biomedical Sciences. Using 3-dimensional culture models is therefore important in ensuring that the behavior of cells in culture is similar to that seen in real life.

The work was mainly carried out by graduate student Weina Meng who formulated the fluorescently labeled nanoparticles and studied them in a variety of tumor and brain cell cultures. Her early studies showed faster uptake of nanoparticles into tumor cell cultures than normal brain cell cultures grown separately. This selectivity was only seen in 3-dimensional cultures and was the driving force to develop a more complex and representative model.

Tumor cell aggregates have been used as cell culture models of cancer cells for many years. Similarly thin brain sl
'/>"/>

Contact: Dr. Martin Garnett
martin.garnett@nottingham.ac.uk
44-011-595-15045
Society for Experimental Biology and Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Novel technology detects human DNA mutations
3. Novel antiviral technology inhibits RSV infection in mice
4. Novel Enzyme Shows Potential As An Anti-HIV Target
5. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
6. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
7. Discovery Could Lead To Novel Approaches In HIV Treatment
8. Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells
9. Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer
10. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy
11. GeneNotes - A novel information management software for biologists

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ing brain chemical with an unwieldy name: 4-hydrox... or used as a date-rape drug. , Now, a team of ...outes by which 4-HB is metabolized by the body. "T...hael Gibson, professor and chair of biological sci...ember of the research team. "It may provide new c...
(Date:11/19/2009)...rop in many countries of the world. It is widely u...rial materials. It also is considered an exemplar ...r evolution, and genome architecture. The authors ...on used the first description of the B73 maize gen... in genetics and plant biology. The ten papers con...
(Date:11/19/2009)..., Nov. 19 BIO-key Intern... in wireless public safety and finger-based biomet...pecial Shareholder Meeting held today was adjourne...was not present. ,, (Logo: http://www.newscom....an impressive 99.3% of the 35 million votes cast v...
Breaking Biology News(10 mins):Researchers begin to decipher metabolism of sexual assault drug 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 1Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 2Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 3Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 4Siperian to Host Webinar With Panel of Pharmaceutical Experts 57355 5Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 1AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 2AEterna Zentaris Partner Keryx Biopharmaceuticals Receives Orphan Drug Designation for Perifosine 28KRX 0401 29 for the Treatment of Multiple Myelo 14093 3
... at today,s "Innovative Devices and Futuristic The...er Cardiovascular Therapeutics (TCT) scientific sy...Foundation, presented 12-month follow-up data from...nt thrombosis in patients discontinuing dual anti-...TA Trial is a first-in-man (FIM), prospective, si...
...e Data Software, WALL, N.J., Oct. 13 BIO-key Int...er in finger-based biometric,identification and wi...additional new public safety software and related ...d quarter of 2008. Approximately fifty percent,of ... new customers and,additional user agencies hosted...
...ke University Medical Center has suggested an enti...on called the flash-lag effect. , Experts have d...flash of light is presented in alignment with a mo...d the position of the object. , "The point of th... of thinking about how this effect can and should ...
Other Biology News:12-month ATLANTA trial data show sustained benefit of Catania Stent 212-month ATLANTA trial data show sustained benefit of Catania Stent 3BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders 2BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders 3Duke team explains a longtime visual puzzler in new way 2
(Date:11/19/2009)... World,s Top Gene Synthesi...ortium (IGSC) to Coordinate Best Practices in Risk...ercent of Worldwide Gene Synthesis Capacity , ...Five of the world’s leading gene synthesis c...apply a common screening protocol to promote biose...
(Date:11/18/2009)... A chemist at the National Institute of Standards ...y simple, inexpensive method for detecting and mea...s and toxins, invisible spoilage in food or pestic...totype method is more sensitive than conventional ..., which are polarlike water molecules, having dist...
(Date:11/18/2009)..., , RICHMOND, Calif., Nov. 18 /PRNewswire-F...GMO ) announced today that data from the Universit...afety study of Sangamo,s zinc finger nuclease (ZFN...ertently and prematurely disclosed on the internet... the University of Pennsylvania School of Medicine...
(Date:11/18/2009)..., , NEW YORK, Nov. 18 R...ch report is available in its catalogue. ,, B...e ,, http://www.reportlinker.com/p0164375/B...e.html#utm_source=prnewswire&utm_medium=pr&...biotechnology are complex chemical compounds used ...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Prototype NIST method detects and measures elusive hazards 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8
...Institute Offers Tips for Coping with the Holiday,...g for millions of women coping with infertility, w...ll of my clients dread Mother,s Day,",says Phyllis...& IVF,Institute (http://www.givf.com ), a compreh...ax, VA. "Women who are distressed by Mother,s Day ...
...s., May 9 Millstone Medical Outsourcing,announced...ISO 13485,certified quality system to the Memphis,...r Standardization, is the world,s largest develope...dition, the company hired Gary,Stevens, a highly-e...anager,for the Memphis location. Millstone, outsou...
...., May 9 InterMune, Inc.,(Nasdaq: ITMN ) today a...tive Officer of InterMune, will present at the Ban...gas on May 14, 2008 at 9:20 a.m. PDT (12:20,p.m ED...tation, investors and other,interested parties may...e,s,corporate website at http://www.intermune.com...
Other Biology Technology:Mother's Day is Devastating for Women Facing Infertility 2Millstone Medical Outsourcing Achieves Quality Advantages in Memphis: Certified ISO 13485, Hires Experienced Quality Manager 2
CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)
CnC (Cn402-05) from European Collection of Cell Cultures (ECACC)
Rabbit Anti-B-FABP (FL-132) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Lambda Protein Phosphatase from New England Biolabs
Biology Products: